产品封面图

Artemisinin

收藏
  • ¥670 - 1116
  • MedChemExpress(MCE)已认证
  • 美国
  • HY-B0094
  • 2026年05月30日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.

    • 英文名

      Qinghaosu; NSC 369397

    • 库存

      货期:1-2天

    • 供应商

      MedChemExpress LLC

    • CAS号

      63968-64-9

    • 规格

      10 mM * 1 mL/200 mg/500 mg

    规格:10 mM * 1 mL产品价格:¥737.0
    规格:200 mg产品价格:¥670.0
    规格:500 mg产品价格:¥1116.0

    MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

    Artemisinin

    CAS No. : 63968-64-9

    MCE 国际站:Artemisinin

    产品活性:Artemisinin (Qinghaosu) 是一种倍半萜烯内酯,从黄花蒿 (Artemisia annua L.) 植物的地上部分分离的抗疟疾活性分子。Artemisinin 以剂量依赖性方式降低 pAKT 来抑制 AKT 信号通路。Artemisinin 可减少癌细胞的增殖,迁移,侵袭,肿瘤发生和转移,同时 Artemisinin 有神经保护作用。

    研究领域:Anti-infection  |  PI3K/Akt/mTOR  |  Apoptosis

    作用靶点:HCV  |  Parasite  |  Akt  |  Ferroptosis

    In Vitro: Artemisinin (Qinghaosu) (25 or 50 μM; 24 hours) concentration-dependently suppresses Aβ25-35 induced cytotoxicity in PC12 cells.
    Artemisinin (1-100 μM; 24 hours) selectively inhibits cancer cell growth in a dose-dependent manner with IC50 values of 31.30 ± 0.73 μM in UMRC-2 cells and 23.97 ± 0.92 CAKI-2 cells.
    Artemisinin (25, 50 μM; 24 hours) suppresses the phosphorylation of AKT in UMRC-2 and CAKI-2 cells in a dose-dependent manner.

    In Vivo: Artemisinin (gavage; 20 mg/kg/day; for two weeks) suppresses UMRC-2 xenograft tumor growth.

    相关产品:Covalent Screening Library Plus  |  Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Apoptosis Compound Library  |  Kinase Inhibitor Library  |  PI3K/Akt/mTOR Compound Library  |  Stem Cell Signaling Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Differentiation Inducing Compound Library  |  Lipid Compound Library  |  Oxygen Sensing Compound Library  |  Ferroptosis Compound Library  |  NMPA-Approved Drug Library  |  Terpenoids Library  |  Glycolysis Compound Library  |  Cytoskeleton Compound Library  |  Glutamine Metabolism Compound Library  |  Traditional Chinese Medicine Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Neuroprotective Compound Library  |  Anti-Hepatitis C Virus Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Lung Cancer Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Antiparasitic Compound library  |  Anti-Cancer Metabolism Compound Library  |  Anti-Obesity Compound Library  |  Angiogenesis-Related Compound Library  |  Glucose Metabolism Compound Library  |  Targeted Diversity Library  |  Anti-Liver Cancer Compound Library   |  Anti-Colorectal Cancer Compound Library   |  Children’s Drug Library  |  Anti-Cancer Natural Product Library  |  Antiviral Traditional Chinese Medicine Active Compound Library  |  Plant-Sourced Natural Product Library  |  FDA-Approved Anticancer Drug Library  |  Anti-Prostate Cancer Compound Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Cancer Stem Cells Compound Library  |  Pain-Related Compound Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Cell Death Library  |  FDA-Approved Traditional Chinese Medicine Active Compound Library  |  Serine/Threonine Kinase Inhibitor Library  |  Ferrostatin-1  |  Erastin  |  Cisplatin  |  Cycloheximide  |  Chloroquine  |  RSL3  |  Acetylcysteine  |  Puromycin dihydrochloride  |  Deferoxamine mesylate  |  Sorafenib  |  ML385  |  Necrostatin-1  |  SP600125  |  MK-2206 dihydrochloride  |  Rosiglitazone  |  Liproxstatin-1  |  Resiquimod  |  Hygromycin B  |  SC79  |  Doxycycline hyclate  |  Curcumin  |  Yoda 1  |  Afatinib  |  Simvastatin  |  Capivasertib  |  Acetaminophen  |  Hemin  |  Anisomycin  |  TBHQ

    热门产品线:重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

    Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

    类药多样性化合物库
    顾客使用MCE产品发表的科研文献
    一站式药筛新体验
    MCE 您身边的生物活性分子大师 | 抑制剂、激动剂、化合物库
    重组蛋白 | 高纯度、高稳定性
    磁珠
    MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥100
    TargetMol中国
    2025年07月14日询价
    询价
    深圳欣博盛生物科技有限公司
    2025年01月11日询价
    ¥2464
    北京孚博生物科技有限公司
    2026年01月20日询价
    询价
    上海瑶韵生物科技有限公司
    2025年07月08日询价
    ¥192
    合肥博美生物科技有限责任公司
    2026年05月27日询价
    Artemisinin
    ¥670 - 1116